<DOC>
	<DOCNO>NCT00062387</DOCNO>
	<brief_summary>Phase II trial study effectiveness perifosine treat patient recurrent metastatic head neck cancer . Drugs use chemotherapy perifosine use different way stop tumor cell divide stop grow die .</brief_summary>
	<brief_title>Perifosine Treating Patients With Recurrent Metastatic Head Neck Cancer</brief_title>
	<detailed_description>OBJECTIVES : I . Determine antitumor activity perifosine patient recurrent metastatic squamous cell head neck cancer . II . Determine time progression overall survival patient treated drug . III . Determine toxicity drug patient . IV . Determine pharmacodynamics drug patient . V. Assess usefulness biomarkers predict response outcome parameter patient treated drug . VI . Assess quality life patient treated drug . OUTLINE : This multicenter study . Patients receive oral perifosine 4 time daily day 1 2 daily day 3-28 course 1 . Patients receive oral perifosine daily day 1-28 subsequent course . Courses repeat every 28 day absence disease progression unacceptable toxicity . Quality life assess baseline , weekly first month , every 28 day first month , study withdrawal . Patients follow every 3 month . PROJECTED ACCRUAL : A total 22-46 patient accrue study within 2 year .</detailed_description>
	<mesh_term>Head Neck Neoplasms</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Histologically cytologically confirm squamous cell cancer head neck Metastatic recurrent disease Not amenable surgery radiotherapy Unidimensionally measurable disease At least 1 lesion least 20 mm conventional technique OR least 10 mm CT scan No known brain metastasis PATIENT CHARACTERISTICS : Age 18 Performance status ECOG 02 OR Karnofsky 60100 % Life expectancy More 3 month Hematopoietic WBC least 3,000/mm^3 Absolute neutrophil count least 1,500/mm^3 Platelet count least 100,000/mm^3 Hepatic Bilirubin normal AST/ALT great 2.5 time upper limit normal Renal Creatinine normal OR Creatinine clearance least 60 mL/min Cardiovascular No symptomatic congestive heart failure No unstable angina pectoris No cardiac arrhythmia Other Not pregnant nursing Negative pregnancy test Fertile patient must use effective contraception No history allergic reaction attribute compound similar chemical biological composition perifosine No ongoing active infection No concurrent uncontrolled illness No psychiatric illness social situation would limit compliance study requirement PRIOR CONCURRENT THERAPY : Biologic therapy No 1 prior biologic/targeted regimen recurrent metastatic disease Chemotherapy No 1 prior adjuvant neoadjuvant chemotherapy and/or concurrent chemoradiotherapy regimen No 1 prior chemotherapy regimen recurrent metastatic disease At least 4 week since prior chemotherapy ( 6 week nitrosoureas mitomycin ) Radiotherapy At least 4 week since prior radiotherapy Other Recovered prior therapy No concurrent combination antiretroviral therapy HIVpositive patient No concurrent investigational agent No concurrent anticancer agent therapy</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2004</verification_date>
	<keyword>stage IV squamous cell carcinoma hypopharynx</keyword>
	<keyword>stage IV squamous cell carcinoma larynx</keyword>
	<keyword>stage IV squamous cell carcinoma lip oral cavity</keyword>
	<keyword>stage IV squamous cell carcinoma nasopharynx</keyword>
	<keyword>stage IV squamous cell carcinoma oropharynx</keyword>
	<keyword>stage IV squamous cell carcinoma paranasal sinus nasal cavity</keyword>
	<keyword>recurrent squamous cell carcinoma hypopharynx</keyword>
	<keyword>recurrent squamous cell carcinoma larynx</keyword>
	<keyword>recurrent squamous cell carcinoma lip oral cavity</keyword>
	<keyword>recurrent squamous cell carcinoma nasopharynx</keyword>
	<keyword>recurrent squamous cell carcinoma oropharynx</keyword>
	<keyword>recurrent squamous cell carcinoma paranasal sinus nasal cavity</keyword>
	<keyword>metastatic squamous neck cancer occult primary squamous cell carcinoma</keyword>
	<keyword>recurrent metastatic squamous neck cancer occult primary</keyword>
	<keyword>recurrent salivary gland cancer</keyword>
	<keyword>salivary gland squamous cell carcinoma</keyword>
	<keyword>stage IV salivary gland cancer</keyword>
</DOC>